Glucose tolerance and chelation therapy in patients with thalassaemia major. - Suppr | 超能文献

Glucose tolerance and chelation therapy in patients with thalassaemia major.

作者信息

Capra L, Atti G, De Sanctis V, Candini G

出版信息

Haematologica. 1983 Jan-Feb;68(1):63-8.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Glucose tolerance and chelation therapy in patients with thalassaemia major.

Haematologica. 1983 Jan-Feb;68(1):63-8.

2

Epidemiology and chelation therapy effects on glucose homeostasis in thalassaemic patients.地中海贫血患者的流行病学及螯合疗法对葡萄糖稳态的影响

J Pediatr Endocrinol Metab. 1998;11 Suppl 3:867-9.

3

Increased risk of diabetes mellitus in beta- thalassemia major due to iron overload.

Helv Paediatr Acta. 1979;34(3):197-207.

4

[Continuous subcutaneous deferoxamine infusions in thalassemia major. Improvement in glucose tolerance].[重型地中海贫血患者持续皮下输注去铁胺。糖耐量改善]

Dtsch Med Wochenschr. 1986 May 2;111(18):698-701. doi: 10.1055/s-2008-1068516.

5

Early iron chelation therapy in thalassemia major.重型地中海贫血的早期铁螯合疗法。

Haematologica. 1983 Jan-Feb;68(1):69-73.

6

[Thalassemia major: chelating therapy with deferoxamine].

Medicina (B Aires). 1985;45(3):231-4.

7

Iron excretion in thalassemia after the administration of chelating agents.地中海贫血患者在使用螯合剂后的铁排泄情况。

Paediatr Indones. 1969 May-Jun;9(3):89-98.

8

Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.美国接受去铁胺治疗的地中海贫血和镰状细胞病患者的治疗结果、医疗服务利用情况及费用

Am J Hematol. 2008 Apr;83(4):263-70. doi: 10.1002/ajh.21049.

9

Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.β地中海贫血的螯合疗法：去铁胺的益处与局限性

Semin Hematol. 1995 Oct;32(4):304-12.

10

Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.

Haematologia (Budap). 1984;17(1):17-24.

引用本文的文献

1

A systematic review of adherence to iron chelation therapy among children and adolescents with thalassemia.铁螯合疗法在儿童和青少年地中海贫血症患者中的依从性的系统评价。

Ann Med. 2022 Dec;54(1):326-342. doi: 10.1080/07853890.2022.2028894.

2

Decrement in Cellular Iron and Reactive Oxygen Species, and Improvement of Insulin Secretion in a Pancreatic Cell Line Using Green Tea Extract.绿茶提取物可降低细胞铁含量和活性氧物质，改善胰岛细胞胰岛素分泌功能。

Pancreas. 2019 May/Jun;48(5):636-643. doi: 10.1097/MPA.0000000000001320.

3

Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload.中间型地中海贫血和铁过载患者的α细胞和β细胞评估

Postgrad Med J. 1985 Nov;61(721):963-7. doi: 10.1136/pgmj.61.721.963.